CDK9 inhibitors push cancer cells over the edge

Matthew W Nowicki, Malcolm D Walkinshaw

Research output: Contribution to journalEditorialpeer-review

Abstract

The trouble with CDK active-site inhibitors is their tendency to have off-target effects. This is not surprising, as the ATP binding sites of most protein kinases are very similar. Wang et al. (2010) have used some clever screening approaches to identify selective CDK9 inhibitors that drive cancer cells into apoptosis.
Original languageEnglish
Pages (from-to)1047-8
Number of pages2
JournalChemistry and Biology
Volume17
Issue number10
DOIs
Publication statusPublished - Oct 2010

Fingerprint

Dive into the research topics of 'CDK9 inhibitors push cancer cells over the edge'. Together they form a unique fingerprint.

Cite this